Diagnostic value of blood urea and bilirubin levels determination in patients with gastroduodenal zone diseases
DOI:
https://doi.org/10.14739/2310-1210.2017.6.114717Keywords:
urea, bilirubin, Helicobacter pylori (HP), gastroduodenal diseases, diseases eradication, biliary tract diseases, pneumoniaAbstract
The study of relationships of urea and bilirubin blood levels in patients with Helicobacter pylori associated gastroduodenal pathology (HP-aGDP) has the considerable relevance for clinicians, since these indicators represent the status and function of the gastroduodenal zone.
The aim of this study was to estimate changes of bilirubin and urea blood levels in patients with HP-aGDP before and after treatment.
Materials and methods. Our study has included 59 patients of the main group with different HP-aGDP and 40 patients of the control group with community-acquired pneumonia (CAP).
Results. In patients with HP-aGDP the doubly severe reduction of urea concentration was observed in significantly greater number of patients, while half of the patients in the controls had an increase of its level by 10.4 %. The bilirubin concentration decrease was more pronounced (37.1 % vs. 3.5 %) and significant (p < 0.05) in patients with HP-aGDP. Its rate depended on the dynamics of urea exactly in patients with HP-aGDP and it was more pronounced in case of urea reduction (p < 0.05). Thus, the revealed association of bilirubin and urea levels changes, namely their decrease owing to the treatment, was inherent only to patients with HP-aGDP unlike to the patients with CAD. We also determined the involvement of lipid, carbohydrate and protein metabolism, electrolytes, composition of blood in the processes of local and systemic inflammation caused by HP and its relationship with adaptive reactions, which generally depended on other individual characteristics of patients in the study group (age, duration of disease, ulcer size, etc.).
Conclusions. The monitoring of urea and bilirubin blood levels in patients especially with HP-aGDP during the eradication has a specific diagnostic and prognostic value. The bilirubin level in such cases reflects the severity of cholestasis, inflammatory lesions of the duodenal mucosa, comorbid hepatobiliary disease, while the urea level reduction may be an additional criterion of efficacy of HP eradication.
References
Nijevitch, A. A., & Loguinovskaya, V. V. (2002) Significance of blood urea: gastric ammonia gradient for H. pylori detection in childhood. Digestive diseases and sciences, 47(1), 65–66.
Zahir, F., Rabbani, G., Khan, R. H., Rizvi, S. J., Jamal, M. S., & Abuzenadah, A. M. (2015) The pharmacological features of bilirubin: the question of the century. Cellular and molecular biology letters, 20(3), 418–447. doi: 10.1515/cmble-2015-0012.
Hamur, H., Duman, H., Demirtas, L., Bakirci, E. M., Durakoglugil, M. E., Degirmenci, H., et al. (2016) Total Bilirubin Levels Predict Subclinical Atherosclerosis in Patients With Prediabetes. Angiology, 67(10), 909–915. doi: 10.1177/0003319716632394.
Akboga, M. K., Canpolat, U., Sahinarslan, A., Alsancak, Y., Nurkoc, S., Aras, D., et al. (2015) Association of serum total bilirubin level with severity of coronary atherosclerosis is linked to systemic inflammation. Atherosclerosis, 240(1), 110–114. doi: 10.1016/j.atherosclerosis.2015.02.051.
Turfan, M., Duran, M., Poyraz, F., Yayla, C., Akboga, M. K., Sahinarslan, A., et al. (2013) Inverse relationship between serum total bilirubin levels and severity of disease in patients with stable coronary artery disease. Coronary artery disease, 24(1), 29–32. doi: 10.1097/MCA.0b013e32835b0c13.
Ginhoux, F., & Jung, S. (2014) Monocytes and macrophages: developmental pathways and tissue homeostasis. Nature reviews. Immunology, 14(6), 392–404. doi: 10.1038/nri3671.
Zhakun, I. B. (2014) Vplyv Helicobacter pylori na stan ta funktsiiu hepatobiliarnoi systemy [The influence of helicobacter pylori infection on the structure and function of the hepatobiliary system]. Hepatolohiia, 4, 6–19. [in Ukrainian].
Zhou, D., Guan, W. B., Wang, J. D., Zhang, Y., Gong, W., & Quan, Z. W. (2013) A comparative study of clinicopathological features between chronic cholecystitis patients with and without Helicobacter pylori infection in gallbladder mucosa. PLoS One, 8(7), e70265. doi: 10.1371/journal.pone.0070265.
Guraya, S. Y., Ahmad, A. A., El-Ageery, S. M., Hemeg, H. A., Ozbak, H. A., Yousef, K., & Abdel-Aziz, N. A. (2015) The correlation of Helicobacter Pylori with the development of cholelithiasis and cholecystitis: the results of a prospective clinical study in Saudi Arabia. European review for medical and pharmacological sciences, 19(20), 3873–3880.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)